Optimal Timing of Cardioverter-Defibrillator Implantation in Patients with Left Ventricular Dysfunction after Acute...

Area of Science:

• Cardiology
• Electrophysiology
• Medical Devices

Background:

• Sudden cardiac death (SCD) prevention post-acute myocardial infarction (AMI) lacks clear guidelines, especially within the first 40 days.
• Existing pivotal studies excluded patients in the early weeks post-AMI, creating a gap in evidence for timely intervention.

Purpose of the Study:

• To evaluate the benefit of early implantable cardiac defibrillator (ICD) implantation in patients following an acute myocardial infarction (AMI).
• To assess the correlation between ejection fraction levels post-AMI and the need for ICD therapy.

Main Methods:

• A retrospective study of 77 AMI patients monitored with continuous ECG and echocardiography.
• Patients with ejection fraction ≤35% at 40 days post-MI received ICDs for primary SCD prevention.
• Follow-up included device interrogation and echocardiography for a median of 38 months.

Main Results:

• Patients with left ventricular ejection fraction (LVEF) <30% post-MI showed a significant correlation with sustained reduced ejection fraction and ICD indication.
• A significant correlation was observed in patients with LVEF between 30-35%, though some exceeded the 35% threshold at 40 days.
• Higher rates of ICD therapies and non-sustained ventricular tachycardia (NSVT) were noted in patients with LVEF <30% and those with initial NSVT detection.

Conclusions:

• Patients may benefit from ICD implantation earlier than the current 40-day waiting period post-AMI.
• Early ICD implantation can mitigate the risk of SCD in patients with persistently low ejection fraction after myocardial infarction.
• The study supports considering early ICD implantation to avoid prolonged exposure to SCD risk.